GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jolt Health Inc (XCNQ:JOLT) » Definitions » Debt-to-Equity

Jolt Health (XCNQ:JOLT) Debt-to-Equity : 0.00 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Jolt Health Debt-to-Equity?

Jolt Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$0.00 Mil. Jolt Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$0.00 Mil. Jolt Health's Total Stockholders Equity for the quarter that ended in Mar. 2024 was C$0.15 Mil. Jolt Health's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Jolt Health's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of Jolt Health was 1.70. The lowest was -3.63. And the median was -0.23.

XCNQ:JOLT's Debt-to-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Jolt Health Debt-to-Equity Historical Data

The historical data trend for Jolt Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jolt Health Debt-to-Equity Chart

Jolt Health Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.19 0.77 -

Jolt Health Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.70 - - - -

Competitive Comparison of Jolt Health's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Jolt Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jolt Health's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jolt Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Jolt Health's Debt-to-Equity falls into.



Jolt Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Jolt Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Jolt Health's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jolt Health  (XCNQ:JOLT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Jolt Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Jolt Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Jolt Health (XCNQ:JOLT) Business Description

Traded in Other Exchanges
Address
355 Burrard Street, Suite 1780, Marine Building, Vancouver, BC, CAN, V6C 2G8
Jolt Health Inc, formerly Love Pharma Inc is a licensee of certain technologies relating to certain controlled substances and pharmaceutical-grade therapeutics. The company is investigating business opportunities in other industries however has not reached a definitive decision to pursue alternative lines of business.

Jolt Health (XCNQ:JOLT) Headlines

No Headlines